We are live on ! Find out more
NBSE

NeuBase Therapeutics, Inc. Common Stock
NBSE

Delisted

NBSE was delisted on the 10th of May, 2024.

Back to rankings

52 hedge funds and large institutions have $22.9M invested in NeuBase Therapeutics, Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 13 increasing their positions, 15 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

139% more capital invested

Capital invested by funds: $9.59M → $22.9M (+$13.3M)

108% more call options, than puts

Call options by funds: $3.27M | Put options by funds: $1.57M

83% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 6

11% more funds holding

Funds holding: 47 → 52 (+5)

13% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 15

Holders
52
Holders Change
+5
Holders Change %
+10.64%
% of All Funds
1.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
13
Reduced
15
Closed
6
Calls
$3.27M
Puts
$1.57M
Net Calls
+$1.7M
Net Calls Change
+$2.71M

Top Buyers

Rank Fund Capital Flow
1
Deutsche Bank
Deutsche Bank
Germany
+$640K
2
ARTA
A.R.T. Advisors
New York
+$533K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$293K
4
BIT
BlackRock Institutional Trust
California
+$223K
5
Neuberger Berman Group
Neuberger Berman Group
New York
+$177K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$450K
2
Group One Trading
Group One Trading
Illinois
-$232K
3
Citadel Advisors
Citadel Advisors
Florida
-$200K
4
FNBT
FineMark National Bank & Trust
Florida
-$115K
5
Goldman Sachs
Goldman Sachs
New York
-$105K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$4.92M +$293K +191 +11%
BIT
2
BlackRock Institutional Trust
California
$2.77M +$223K +145 +15%
BBA
3
Baker Bros. Advisors
New York
$2.27M – – –
KCM
4
Knoll Capital Management
Florida
$1.26M – – –
Deutsche Bank
5
Deutsche Bank
Germany
$1.16M +$640K +417 +758%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$903K -$6.14K -4 -1%
ARTA
7
A.R.T. Advisors
New York
$851K +$533K +347 New
PNC Financial Services Group
8
PNC Financial Services Group
Pennsylvania
$740K +$49.1K +32 +12%
SIP
9
Stoneridge Investment Partners
Pennsylvania
$678K -$66K -43 -13%
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
$622K -$450K -293 -54%
GBA
11
Garrison Bradford & Associates
New York
$555K -$12.3K -8 -3%
HF
12
Hoxton Financial
West Virginia
$531K – – –
California Public Employees Retirement System
13
California Public Employees Retirement System
California
$484K – – –
BFA
14
BlackRock Fund Advisors
California
$435K +$9.21K +6 +4%
LCM
15
Leisure Capital Management
California
$419K +$7.67K +5 +3%
BIC
16
Beach Investment Counsel
Pennsylvania
$318K – – –
Northern Trust
17
Northern Trust
Illinois
$316K +$16.9K +11 +9%
CCB
18
Cutter & Co Brokerage
Missouri
$292K -$21.5K -14 -11%
Neuberger Berman Group
19
Neuberger Berman Group
New York
$284K +$177K +115 New
PP
20
PDT Partners
New York
$270K +$169K +110 New
Bank of New York Mellon
21
Bank of New York Mellon
New York
$258K +$41.4K +27 +35%
New York State Common Retirement Fund
22
New York State Common Retirement Fund
New York
$251K – – –
HighTower Advisors
23
HighTower Advisors
Illinois
$183K -$6.14K -4 -5%
Balyasny Asset Management
24
Balyasny Asset Management
Illinois
$172K +$15.4K +10 +17%
Dimensional Fund Advisors
25
Dimensional Fund Advisors
Texas
$169K +$106K +69 New
1
2 3

NBSE Hedge Fund Activity: Q4 2015 in Review

52 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in NeuBase Therapeutics, Inc. Common Stock (NBSE) for Q4 2015, worth a combined $22.9M — up 139% from $9.59M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new NBSE positions and 6 closed out — a net gain of 5 holders — while 13 added to existing stakes and 15 trimmed.

The largest buyer was Deutsche Bank, adding an estimated $640K. The largest seller was Susquehanna International Group, cutting an estimated $450K.

  • 52 institutional investors held NeuBase Therapeutics, Inc. Common Stock (NBSE) as of Q4 2015, up from 47 in Q3 2015.
  • Funds reported $22.9M of NeuBase Therapeutics, Inc. Common Stock stock for Q4 2015, up 139% quarter-over-quarter.
  • 11 funds opened new NeuBase Therapeutics, Inc. Common Stock positions in Q4 2015 and 6 closed out, a net change of +5 holders.
  • The largest NeuBase Therapeutics, Inc. Common Stock buyer in Q4 2015 was Deutsche Bank, an estimated $640K added.
  • The largest NeuBase Therapeutics, Inc. Common Stock seller in Q4 2015 was Susquehanna International Group, an estimated $450K sold.

Based on aggregated 13F filings for Q4 2015.